A Randomized Phase II Trial Of PS-341 And Gemcitabine In Patients With Metastatic Pancreatic Adenocarcinoma
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Bortezomib (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 30 Oct 2007 Status change
- 03 Sep 2005 New trial record.